Statistics
Publications
129
Citations
10.6K
H-Index
49
Active since
2003
Peter Martin is an author at Cornell University specializing in oncology, medicine, and hematologic oncology.
Publications per year
2003–2025
129
129
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
Michael Wang, Simon Rule, Peter Martin et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text
Medicine, Hematology, Pharmacology +17
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Ajay K. Gopal, Brad S. Kahl, Sven de Vos et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +17
Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma
Peter Martin, Amy Chadburn, Paul J. Christos et al. · Journal of Clinical Oncology · 2009 · 339 citations
Medicine, Oncology, Chemotherapy +11
1–5 of 129